BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12371314)

  • 1. [Possibilities of immunosuppressive therapy in reconstructive keratoplasty (experience gained in the use of cyclosporin)].
    Kasparov AA; Aladinskaia IV
    Vestn Oftalmol; 2002; 118(4):16-8. PubMed ID: 12371314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Keratoplasty with scleral rim after the most severe chemical eye burns of the anterior eye segment].
    Redbrake C; Buchal V
    Klin Monbl Augenheilkd; 1996 Mar; 208(3):145-51. PubMed ID: 8699771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The surgical characteristics of patients with postburn vascularized leukomas].
    Saporovskiĭ SS; Lebekhov PI; Kugleev AA
    Oftalmol Zh; 1990; (5):257-61. PubMed ID: 2089318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study of the efficacy of cyclosporine used in patients at high risk of keratograft rejection. Communication 1. Results of clinical monitoring].
    Makarov PV; Balaian TG; Oganesian OG; Slepova OS; Bykovskaia GN; Iluridze SL
    Vestn Oftalmol; 2007; 123(4):14-9. PubMed ID: 17802754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Limbal autograft and allograft transplantations in patients with corneal burns.
    Ozdemir O; Tekeli O; Ornek K; Arslanpençe A; Yalçindağ NF
    Eye (Lond); 2004 Mar; 18(3):241-8. PubMed ID: 15004571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Amniotic membrane transplantation with limbal stem cell transplantation as a combined procedure for corneal surface reconstruction after severe thermal or chemical burns].
    Stoiber J; Ruckhofer J; Muss W; Grabner G
    Ophthalmologe; 2002 Nov; 99(11):839-48. PubMed ID: 12430036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Factors of graft failure after chemical corneal injury].
    Feng CM; Chen JQ; Li YP
    Zhonghua Yan Ke Za Zhi; 1994 Jul; 30(4):277-9. PubMed ID: 7843018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Systemic cyclosporin A therapy in high risk keratoplasty].
    Bialasiewicz AA; Naumann GO
    Fortschr Ophthalmol; 1989; 86(6):574-80. PubMed ID: 2625283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical 0.03% tacrolimus preventing rejection in high-risk corneal transplantation: a cohort study.
    Magalhaes OA; Marinho DR; Kwitko S
    Br J Ophthalmol; 2013 Nov; 97(11):1395-8. PubMed ID: 24008822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tenon-plasty and early keratoplasty in severe chemical eye burns].
    Kuckelkorn R; Redbrake C; Kottek A; Feldmann P; Reim M
    Ophthalmologe; 1995 Aug; 92(4):439-44. PubMed ID: 7549326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Donor source affects the outcome of ocular surface reconstruction in chemical or thermal burns of the cornea.
    Shimazaki J; Shimmura S; Tsubota K
    Ophthalmology; 2004 Jan; 111(1):38-44. PubMed ID: 14711712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunosuppressive therapy with cyclosporin A following penetrating keratoplasty].
    Gnad HD; Skorpik C; Radda TM; Paroussis P; Menapace R; Klemen UM
    Klin Monbl Augenheilkd; 1985 Nov; 187(5):398-400. PubMed ID: 3910946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of the sequelae of ocular burns using limbal transplantation].
    Borderie V; Touzeau O; Bourcier T; Allouch C; Scheer S; Laroche L
    J Fr Ophtalmol; 2003 Sep; 26(7):710-6. PubMed ID: 13130258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Surgical technique of limbal autotransplantation in severe and recent eye burns].
    Gérard M; Merle H; Chiambaretta F; Louis V; Richer R; Rigal D
    J Fr Ophtalmol; 1999 May; 22(4):502-6. PubMed ID: 10365341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative results of optic interlamellar keratoplasty in leukomas and therapeutic-tectonic transplantation in experimental chemical burns of the cornea].
    Morkhat IV
    Oftalmol Zh; 1975; 30(2):116-21. PubMed ID: 1094359
    [No Abstract]   [Full Text] [Related]  

  • 16. Long-term outcomes of penetrating keratoplasty in chronic and delayed mustard gas keratitis.
    Javadi MA; Yazdani S; Kanavi MR; Mohammadpour M; Baradaran-Rafiee A; Jafarinasab MR; Einollahi B; Karimian F; Zare M; Naderi M; Rabei HM
    Cornea; 2007 Oct; 26(9):1074-8. PubMed ID: 17893537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cyclosporin A combined with dexamethasone in preventing and treating immune rejection after penetrating keratoplasty].
    Xi XH; Qin B; Jiang DY
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):627-30. PubMed ID: 15804077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Retrospective analysis of deep lamellar keratoplasties].
    Bodenmueller M; Goldblum D; Frueh BE
    Klin Monbl Augenheilkd; 2004 May; 221(5):307-10. PubMed ID: 15162268
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Keratoplasty after mustard gas injury: clinical outcome and histology.
    Richter MN; Wachtlin J; Bechrakis NE; Hoffmann F
    Cornea; 2006 May; 25(4):467-9. PubMed ID: 16670487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical features of immune rejection after corneoscleral transplantation.
    Shi W; Wang T; Zhang J; Zhao J; Xie L
    Am J Ophthalmol; 2008 Nov; 146(5):707-13. PubMed ID: 18707671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.